Skip to content
ITCI Intra-Cellular Therapies Inc.
$127.08 -0.06% -0.07
Notify me if price changes either direction
Interactive Brokers Logotype

Buy ITCI stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 13.5B
Enterprise value 12.5B
Trailing PE -86.99999770073
Forward PE 488.84616
PEG Ratio 488.84616
Enterprise to EBITDA -103.134
Enterprise to revenue 20.348
Price to book MRQ 11.768518
Price to sales TTM 22.0026

Financials

Fiscal Year Ends 2023-12-31
Most Recent Quarter (MRQ) 2024-09-30
Revenue (TTM) 613.7M
EBITDA -121086000
Diluted EPS TTM -0.86
Total Cash (MRQ) 1B
Current ratio (MRQ) 7.656
Operating Cash Flow (TTM) -62160000

ITCI trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
75% sells
25% buys
Upgrade Today
In the last 0 months

Recent ITCI News

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account?

Services

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.